Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Topiramate 50mg capsules |
| BNF code | 040801050AAAWAW |
| Virtual Therapeutic Moiety | Topiramate |
| Date identifier became valid | 19 Oct 2018 |
| Previous product identifier | 134539006 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | capsule |
| Unit dose unit of measure | capsule |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Topiramate |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 50.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | capsule.oral |
| Dose Form | |
| Formulation | Oral capsule |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Topamax 50mg sprinkle capsules (CST Pharma Ltd) | |
| Topamax 50mg sprinkle capsules (Janssen-Cilag Ltd) | |
| Topamax 50mg sprinkle capsules (Lexon (UK) Ltd) | |
| Virtual Medicinal Product Packs | |
| Topiramate 50mg capsules 60 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.